The University of Manchester

#Blood clotting #Fibrinogen #Proteins #The University of Manchester #Wound care #Wound healing

Fibrinogen discovery reshapes our understanding of how wounds heal

Scientists have redefined how the key blood‑clotting protein fibrinogen behaves when it contacts air, overturning two decades of scientific consensus on wound healing. The study, ‘Redefining Fibrinogen Self Assembly at the Air–Water Interface: An Intriguing Story with Multiple Layers’, is the culmination of over a decade of international collaboration by… Read More

#News

#Brain cancer #Chemotherapy #Oncology #The University of Manchester

Glioblastoma therapy timing could be key to treatment

Scientists have identified a brief window after brain tumour surgery during which a treatment for glioblastoma can cross the brain’s protective barrier and reach the cancer cells most likely to trigger tumour regrowth.  The discovery could pave the way for more effective treatments for glioblastoma, the most… Read More

#Cancer Research #Editor's Choice #News

Heart
#Clinical trial #Drug discovery #Heart disease #The University of Manchester

New drug could treat common heart disease, study shows 

A new drug that reduces heart muscle thickening could represent a new treatment option for heart disease patients, a study says.  The TEMPEST trial, led by researchers at the University of Manchester, tested the drug trientine in 154 adults with hypertrophic cardiomyopathy in a year-long, placebo-controlled study. Read More

#News

Child with eczema
#Bacteria #Eczema #The University of Manchester

Bacteria could treat inflammatory skin conditions, research finds  

Skin bacteria could hold the key to safe treatments for eczema, new research suggests.  A study led by scientists at The University of Manchester and Tokyo University of Agriculture and Technology found that harmless microbes living on our skin release powerful molecules, shutting down inflammation triggered by Staphylococcus… Read More

#News

A laboratory mouse
#ischaemic stroke #Stroke #The University of Manchester

Clot-busting drug could harm stroke treatment response 

A clot-busting drug may stop promising stroke medicine from working properly, research reveals.  Researchers at the University of Manchester found the clot-busting therapy, known as tissue plasminogen activator (tPA), interacts negatively with the anti-inflammatory treatment anakinra, highlighting the need for new stroke therapies alongside existing standard care. Read More

#News

Lab of the future
#Cancer #The University of Manchester #UK

New UK lab to accelerate cancer diagnostic solutions 

A new state-of-the-art lab has opened in the UK to accelerate the development of cancer diagnostic solutions.  Vortex Biotech has opened a new laboratory at Manchester Science Park, hoping to accelerate the development of cancer diagnostic solutions. The laboratories are designed to GLP-ready specifications, allowing future expansion into clinical trial support and commercial product… Read More

#Cancer Research #News

#ALS #Antibody drug conjugate (ADC) #Breast cancer #Cancer research #DDW Turning Science into Business Symposium #Gene therapy #Hunter Syndrome #Neurodegenerative disorders #Oncology #The University of Manchester #University of California San Diego

This week in Drug Discovery (24 – 28 November) 

News round-up for 24 – 28 November by Bruno Quinney, Content Team at DDW.  This week in drug discovery, gene therapies are providing solutions for complex conditions, most notably in Hunter syndrome but also in amyotrophic lateral sclerosis. Elsewhere, an antibody-drug conjugate precision therapy could prevent breast cancer. … Read More

#News

Stem cell transplant
#Gene therapy #Hunter Syndrome #The University of Manchester

Revolutionary therapy treats Hunter syndrome for first time 

A world-first therapy has provided an unprecedented step towards treating the devastating condition Hunter syndrome.  Researchers at the University of Manchester treated a three-year-old boy, Ollie Chu, with a stem cell gene therapy treatment developed by the university. Several months on from the procedure performed in… Read More

#News

Blood cells
#ischaemic stroke #Preclinical investigations #Stroke #The University of Manchester

New drug a potential breakthrough for stroke treatment

A new clot-busting drug has been shown in preclinical investigations to be significantly better at treating ischaemic stroke than existing therapies.  The compound, known as caADAMTS13, could be a breakthrough for patients who have brain blood clots with an overabundance of platelets.  The study, funded… Read More

#Editor's Choice #News

Genetics
#Colorectal cancer #Genetics / genomics #The Institute of Cancer Research #The University of Manchester #University of Leeds #University of Oxford

Genetic causes of colorectal cancer revealed in new study

A new study has provided the most comprehensive analysis to date of the genetic makeup of colorectal cancer (CRC), providing unique understanding of its response to treatment. The research was led by UK universities, including the University of Oxford, The Institute of Cancer Research, London, the… Read More

#Cancer Research #News

Bacteria in Petri dishes
#Antibiotic resistance #Antibiotics #Antimicrobial resistance (AMR) #Bacteria #The University of Manchester

New understanding of bacteria mutation rates could combat AMR

Scientists have discovered a way to control mutation rates in bacteria, introducing the possibility of new strategies to combat antimicrobial resistance (AMR). The researchers used high-performance computing to simulate more than 8,000 years of bacterial evolution, allowing scientists to predict mechanisms that control mutation rates. Read More

#Editor's Choice #News

Peptide
#Environmental impact #Oncology #Peptides #Sustainability #The University of Manchester

Discovery offers greener and more efficient peptide production

Scientists from the University of Manchester have uncovered a more efficient and sustainable way to make peptide-based medicines, showing promising effectiveness in combating cancers. Peptides are used in many medicines, as well as in vaccines and nanomaterials. However, making peptides in the lab is currently a… Read More

#Cancer Research #News

#Cell culture #Cell Science #Nanomedicine / nanotechnology #Organoids #The University of Manchester

Lung organoids provide animal alternative for nanomaterial testing

Lung organoids grown by University of Manchester scientists have been shown to mimic the response of animals when exposed to certain nanomaterials. The study at the University’s NanoCell Biology Lab at the Centre for Nanotechnology in Medicine is published in the journal Nano Today. Read More

#Editor's Choice #News

RNA research
#Regenerative Medicine #RNA #Small RNA #The University of Manchester #Wound care

Small RNAs promote wound-healing without scarring

A class of molecules playing a crucial role in the regulation of gene expression and other cellular processes can restore normal skin structure rather than producing a scar, a University of Manchester-led study suggests. The new findings show that microRNA-29s, a class of small RNAs, could… Read More

#Editor's Choice #News

Osteoarthritis
#Link Biologics #Osteoarthritis #Preclinical investigations #The University of Manchester

Research reveals promising novel treatment for osteoarthritis

Researchers from the University of Manchester and Link Biologics have revealed preclinical data on a potential new treatment for osteoarthritis. The results were published in a paper in journal Osteoarthritis and Cartilage, which describes the development of a protein biological drug termed Link_TSG6 with disease modifying… Read More

#Editor's Choice #News

#Antibodies #Target identification #The University of Manchester

University of Manchester expands antibody characterisation research   

The University of Manchester has added an instrument by Carterra to its Biomolecular Analysis Core Facility (BACF) within the Faculty of Biology, Medicine and Health (FBMH). The University has added Carterra’s LSA instrument to help assist with the development and characterisation of antibodies.   Created in 2005, the… Read More

#News